AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $133,003 | -6.4% | 782,372 | 0.0% | 0.09% | -17.4% |
| Q1 2023 | $142,157 | -61.3% | 782,372 | 0.0% | 0.11% | -63.4% |
| Q4 2022 | $367,637 | -25.4% | 782,372 | 0.0% | 0.30% | -26.4% |
| Q3 2022 | $493,000 | -35.0% | 782,372 | +3.2% | 0.40% | -27.4% |
| Q2 2022 | $758,000 | -16.7% | 758,144 | 0.0% | 0.56% | -7.6% |
| Q1 2022 | $910,000 | -9.1% | 758,144 | +13.7% | 0.60% | -0.8% |
| Q4 2021 | $1,001,000 | +31.5% | 667,085 | +42.8% | 0.61% | +16.2% |
| Q3 2021 | $761,000 | -5.8% | 467,085 | 0.0% | 0.52% | +1.4% |
| Q2 2021 | $808,000 | -26.5% | 467,085 | +12.1% | 0.52% | -36.6% |
| Q1 2021 | $1,100,000 | -99.8% | 416,584 | +6.4% | 0.82% | +23.4% |
| Q4 2020 | $724,430,000 | +106277.4% | 391,584 | 0.0% | 0.66% | +1.7% |
| Q3 2020 | $681,000 | -99.9% | 391,584 | 0.0% | 0.65% | -22.3% |
| Q2 2020 | $853,653,000 | +319620.2% | 391,584 | +112.5% | 0.84% | +201.1% |
| Q1 2020 | $267,000 | -10.1% | 184,258 | +8.6% | 0.28% | +104.4% |
| Q4 2019 | $297,000 | – | 169,663 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 426,297 | $1,965,000 | 0.78% |
| Vivo Capital, LLC | 527,842 | $2,433,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,158 | $3,772,000 | 0.20% |
| NEA Management Company, LLC | 452,167 | $2,084,000 | 0.08% |
| Hikari Power Ltd | 60,012 | $277,000 | 0.04% |
| Baker Brothers Advisors | 496,901 | $2,291,000 | 0.02% |
| QVT Financial LP | 132,077 | $531,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 214,126 | $987,000 | 0.00% |
| Virtu KCG Holdings LLC | 12,472 | $57,000 | 0.00% |
| Advisor Group, Inc. | 6,381 | $29,000 | 0.00% |